Have just been going back over metrix on MLL and have topped up a little - I cant believe this is trading at these levels and have started topping up
Even applying only 10% of the NPV of Goulamina and 50% value of plant (nil value in land) the asset value is 4.50x the Enterprise Value
assuming 50% of NPV of Goulamina the asset value is 12x the Enterprise Value
some very good short term upside in my opinion
No debt, gold producer next week, ready to rumble lithium project with ~$40'm cash in the bank. My view downside is very limited
Shares 720,437,376 SPP 61,468,750 Total 781,906,126 Options Oct-21 Expiry 0.15 29,066,018 Total Shares exc 40c options 810,972,144 Share Price 0.155 Fully Diluted Market Cap 125,700,682 Capital Raise Cash SPP 9,835,000 47,602,216 T1 7,616,355 348,883,034 T2 55,821,285 Total Cash 73,272,640 Less Morila Acquisition $27,000,000 USD 0.71 38,028,169 Remaining Cash 35,244,471 Cash from 15c options 4,359,903 Total Cash 39,604,374 Enterprise Value 86,096,309 Assets Morila - 50% replacement cost plan $300,000,000 USD $211,267,606 AUD Morila - exploration land - Nil value Goulamina - 50% NPV $1,700,000,000 AUD $850,000,000 AUD Asset Value $1,061,267,606 AUD Multiple to Enterprise Value 12.33x Assets Morila - 50% replacement cost plan $300,000,000 USD $211,267,606 AUD Morila - exploration land - Nil value Goulamina - 10% NPV $1,700,000,000 AUD $170,000,000 AUD Asset Value $381,267,606 AUD Multiple to Enterprise Value 4.43x
- Forums
- ASX - By Stock
- FFX
- Current SP and any other thoughts
Current SP and any other thoughts, page-7547
-
-
- There are more pages in this discussion • 182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online